DXR - NASDAQ

Daxor Corporation

Daxor Corporation

DXRยทNASDAQ

$11.09

+7.6%
HealthcareMedical - Instruments & Supplies

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$55.86M
EPS1.8400
P/E Ratio6.03
Earnings Date08/20/2026
Daxor Corporation

Daxor Corporation Fair Value Envelope

DXR ยท NASDAQ

Our analysis suggests that DXR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.0866, this represents a potential HIDDEN relative to our calculated worth for Daxor Corporation.

HIDDEN
Intrinsic Value
Current Price: $11.0866

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$520.8K
+ Cash & Equivalents$0
Firm Value-$520.8K
- Debt$112.0K
Equity Value-$632.8K
/ Shares Outstanding4,984,452B
DCF Value-$0
OVERVALUED BY 101%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$302.2K
-$151.1K
-$75.6K
-$37.8K
-$18.9K
-$9.4K
-$4.7K
-$2.4K
-$1.2K
-$590
Maintenance CapEx
-$0
-$0
-$0
-$0
-$0
-$0
-$0
-$0
-$0
-$0
Owner Earnings
-$302.2K
-$151.1K
-$75.6K
-$37.8K
-$18.9K
-$9.4K
-$4.7K
-$2.4K
-$1.2K
-$590
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$279.8K
-$129.5K
-$60.0K
-$27.8K
-$12.9K
-$6.0K
-$2.8K
-$1.3K
-$591
-$273
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your DXR research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.